Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription


27.02.2023

5 Blood
1 BMC Cancer
2 Br J Haematol
3 Cancer
1 Eur J Haematol
2 Haematologica
1 Int J Radiat Oncol Biol Phys
1 Leukemia
1 Mod Pathol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. NEELAPU SS, Jacobson CA, Ghobadi A, Miklos DB, et al
    5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1).
    Blood. 2023 Feb 23:blood.2022018893. doi: 10.1182/blood.2022018893.
    PubMed         Abstract available

  2. RODDIE C, Lekakis LJ, Marzolini MAV, Ramakrishnan A, et al
    Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma.
    Blood. 2023 Feb 23:blood.2022018598. doi: 10.1182/blood.2022018598.
    PubMed         Abstract available

  3. CAIRO MS
    EBV: the virus that keeps on giving!
    Blood. 2023;141:689-691.
    PubMed        

  4. KHODADOUST MS, Mou E, Kim YH
    Integrating novel agents into the treatment of advanced mycosis fungoides and Sezary syndrome.
    Blood. 2023;141:695-703.
    PubMed         Abstract available

  5. ELITZUR S, Vora A, Burkhardt B, Inaba H, et al
    EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.
    Blood. 2023;141:743-755.
    PubMed         Abstract available


    BMC Cancer

  6. LEI T, Wu G, Xu Y, Zhuang W, et al
    Peripheral immune cell profiling of double-hit lymphoma by mass cytometry.
    BMC Cancer. 2023;23:184.
    PubMed         Abstract available


    Br J Haematol

  7. BELOT A, Camus V, Portugues C, Paget J, et al
    Long-term excess mortality and net survival among elderly diffuse large B-cell lymphoma patients after front-line R-CHOP treatment.
    Br J Haematol. 2023 Feb 22. doi: 10.1111/bjh.18705.
    PubMed         Abstract available

  8. WILSON MR, Barrett A, Cheah CY, Eyre TA, et al
    How I manage mantle cell lymphoma: indolent versus aggressive disease.
    Br J Haematol. 2023 Feb 20. doi: 10.1111/bjh.18697.
    PubMed         Abstract available


    Cancer

  9. CHO J, Kim E, Yoon SE, Kim SJ, et al
    TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
    Cancer. 2023 Feb 22. doi: 10.1002/cncr.34698.
    PubMed         Abstract available

  10. ALEMAN BMP, Krul IM, Janus CPM, van der Maazen RWM, et al
    Reply to "Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?".
    Cancer. 2023 Feb 24. doi: 10.1002/cncr.34713.
    PubMed        

  11. CHAKRABARTI D, Brahma Bhatt ML
    Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?
    Cancer. 2023 Feb 24. doi: 10.1002/cncr.34712.
    PubMed        


    Eur J Haematol

  12. GAO H, Lin N, Gu Z, Zhao S, et al
    Up-front Autologous Hematopoietic Stem Cell Transplantation After First Complete Remission Improved Prognosis of Advanced Extra nodal NKT Cell Lymphoma: A Multicenter Real-World Study in China.
    Eur J Haematol. 2023 Feb 24. doi: 10.1111/ejh.13950.
    PubMed         Abstract available


    Haematologica

  13. BARRACLOUGH A, England JT, Villa D, Wight J, et al
    Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.
    Haematologica. 2023 Feb 23. doi: 10.3324/haematol.2022.281375.
    PubMed         Abstract available

  14. BEWARDER M, Kaddu-Mulindwa D, Kos IA, Lesan V, et al
    Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R) - CHOP.
    Haematologica. 2023 Feb 23. doi: 10.3324/haematol.2022.282126.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  15. LEVIS M, Campbell BA, Matrone F, Grapulin L, et al
    Peri-transplant radiotherapy in refractory or relapsed Hodgkin lymphoma patients undergoing autologous stem cell transplant: long term results of a retrospective study of the Fondazione Italiana Linfomi (FIL).
    Int J Radiat Oncol Biol Phys. 2023 Feb 21:S0360-3016(23)00165.
    PubMed         Abstract available


    Leukemia

  16. GOSSAI N, Bhojwani D, Schafer ES, Chang BH, et al
    Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study.
    Leukemia. 2023 Feb 22. doi: 10.1038/s41375-023-01856.
    PubMed        


    Mod Pathol

  17. BERENDSEN MR, Bladel DAGV, Hesius E, de Groot FA, et al
    Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences.
    Mod Pathol. 2023;36:100119.
    PubMed         Abstract available


    PLoS One

  18. THEAKSTONE AG, Brennan PM, Jenkinson MD, Goodacre R, et al
    Investigating centrifugal filtration of serum-based FTIR spectroscopy for the stratification of brain tumours.
    PLoS One. 2023;18:e0279669.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: